Clinical Trial
Levamisole in cases of E.N.L
- PMID: 3897404
Item in Clipboard
Clinical Trial
Levamisole in cases of E.N.L
Indian J Lepr.
1985 Jan-Mar.
Abstract
Levamisole, the anthelmintic drug was tried in ENL (Erythema Nodosum Leprosum) cases using double blind control trial in dosage of 150 mg/day on three consecutive days for three months. It was found that levamisole was not effective in ENL cases and no severe side effect was seen in these cases.
Similar articles
-
Levamisole in the treatment of E.N.L. in leprosy.Indian J Lepr. 1985 Jan-Mar;57(1):1-10. Indian J Lepr. 1985. PMID: 3897402 Clinical Trial. No abstract available.
-
A comparative evaluation of levamisole in leprosy.Indian J Lepr. 1985 Jan-Mar;57(1):11-6. Indian J Lepr. 1985. PMID: 3839808
-
Oral zinc in recurrent Erythema Nodosum Leprosum reaction.Lepr India. 1983 Jul;55(3):547-52. Lepr India. 1983. PMID: 6656212
-
Erythema nodosum leprosum in a general hospital.Arch Dermatol. 1975 Dec;111(12):1575-80. Arch Dermatol. 1975. PMID: 1106330 Review.
-
The role of thalidomide in the management of erythema nodosum leprosum.Lepr Rev. 2007 Sep;78(3):197-215. Lepr Rev. 2007. PMID: 18035771 Review.
Cited by
-
Interventions for erythema nodosum leprosum.Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006949. doi: 10.1002/14651858.CD006949.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical